Lipidomics of cyclophosphamide 4-hydroxylation in patients receiving post-transplant cyclophosphamide.
Saved in:
| Title: | Lipidomics of cyclophosphamide 4-hydroxylation in patients receiving post-transplant cyclophosphamide. |
|---|---|
| Authors: | Navarro SL; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Zheng Z; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Randolph TW; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Nakamura R; Department of Hematologic Malignancies Translational Sciences, City of Hope, Duarte, California, USA.; Department of Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California, USA., Sandmaier BM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Hockenbery D; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., McCune JS; Department of Hematologic Malignancies Translational Sciences, City of Hope, Duarte, California, USA.; Department of Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California, USA. |
| Source: | Clinical and translational science [Clin Transl Sci] 2022 Nov; Vol. 15 (11), pp. 2772-2780. Date of Electronic Publication: 2022 Sep 24. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
